Rennova Health (RNVAD) Stock Price, News & Analysis

Company Overview

Rennova Health, Inc. provides diagnostics and supportive software solutions to healthcare providers. The Company's solutions include diagnostic solutions, revenue cycle management, healthcare software solutions, financial services, diagnostic laboratory testing and analytics for precision medicine, electronic health records and other software services. Rennova Health, Inc., formerly known as CollabRx, Inc., is headquartered in West Palm Beach, Florida.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 1.28 million shs
• Market Capitalization: $318.79 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RNVAD Stock Analysis - Frequently Asked Questions

When did Rennova Health's stock split?

Rennova Health's stock reverse split on the morning of Wednesday, March 16th 2022. The 1-10000 reverse split was announced on Wednesday, March 16th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, March 16th 2022. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

How do I buy shares of Rennova Health?

Shares of RNVAD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 2/21/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: General Medical & Surgical Hospitals
• Sub-Industry: Healthcare
• Current Symbol: OTCMKTS:RNVAD
• CUSIP: N/A
• CIK: 931059
• Web: www.rennovahealth.com
• Phone: 561-855-1626
• Fax: 415-248-5351
• Employees: 60
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-18,340,000.00
• Net Margins: N/A
• Pretax Margin: -476.63%
• Return on Equity: N/A
• Return on Assets: -77.55%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.05
• Quick Ratio: 0.05

Sales & Book Value

• Annual Sales: $7.20 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 44,276,552,000
• Free Float: 19,694,210,000
• Market Cap: $318.79 million
• Optionable: Not Optionable
• Beta: 18.08